Latest research

Italian researchers found that an online meditation course was an effective treatment to improve psychological well-being in the short term.

Results of clinical trial suggest that siponimod slows down progression in secondary progressive multiple sclerosis - SPMS.

Study finds people experiencing greater levels of stigma reported more symptoms of depression.

A public consultation on guidance on the use of disease modifying drugs (DMDs) for people in England with relapsing MS is open until 5 May 2018

Preliminary data from an international stem cell study for people with relapsing multiple sclerosis has reported that those having stem cell treatment had fewer relapses and improved disability levels.

The effect of textured insoles on balance and walking were analysed in this review.

Healthier diet and lifestyle was associated with lower levels of disability and symptom severity in a research study of nearly 7000 people with MS.

This research evaluated a new cardboard version of the nine hole peg test for assessing hand and arm function.

Ibudilast slowed down the loss of brain volume in primary and secondary progressive MS by almost one half compared to placebo according to results presented at ECTRIMS 2017.

Researchers evaluated the Nintendo Wii as a resource to help people with MS exercise more frequently.

Results of a small study suggest that clemastine, a drug used to treat allergies, may repair damage to myelin in the optic nerve of people with MS.

Researchers investigated gender differences in how older men and women experience ageing with MS.